Related references
Note: Only part of the references are listed.DT390-triTMTP1, a Novel Fusion Protein of Diphtheria Toxin with Tandem Repeat TMTP1 Peptide, Preferentially Targets Metastatic Tumors
Xiangyi Ma et al.
MOLECULAR PHARMACEUTICS (2013)
Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD
Ronghua Liu et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Development of Peritoneal Tumor-Targeting Vector by In Vivo Screening with a Random Peptide-Displaying Adenovirus Library
Takeshi Nishimoto et al.
PLOS ONE (2012)
Anti-Tumor Effects of the Peptide TMTP1-GG-D(KLAKLAK)2 on Highly Metastatic Cancers (Publication with Expression of Concern. See vol. 15, 2020)
Xiangyi Ma et al.
PLOS ONE (2012)
Enhanced Metastasis Suppression by Targeting TRAIL Receptor 2 in a Murine Model of Triple-Negative Breast Cancer
Dmitry Malin et al.
CLINICAL CANCER RESEARCH (2011)
Promise and Challenge of RNA Interference-Based Therapy for Cancer
Fabio Petrocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A peptide binding to dimerized translationally controlled tumor protein modulates allergic reactions
Miyoung Kim et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer
Tracy Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tumor-targeted delivery of biologically active TRAIL protein
H-Y Zhang et al.
CANCER GENE THERAPY (2010)
Making the Investigational Oncology Pipeline More Efficient and Effective: Are We Headed in the Right Direction?
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2010)
Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation
Annie Yang et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer
Jean-Charles Soria et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TRAILing death in cancer
Gregory Mellier et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells
Andrea Mohr et al.
STEM CELLS (2010)
Screening and Identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library
Linquan Zang et al.
CANCER LETTERS (2009)
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
Peter A. Holoch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo
Shuxian Song et al.
FASEB JOURNAL (2009)
A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein
Susanne Dymalla et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
MECHANISMS OF DISEASE Cell Death
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Betulin Is a Potent Anti-Tumor Agent that Is Enhanced by Cholesterol
Franziska B. Mullauer et al.
PLOS ONE (2009)
TMTP1, a novel tumor-homing peptide specifically targeting metastasis
Wanhua Yang et al.
CLINICAL CANCER RESEARCH (2008)
Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
Edwin Bremer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Metastasis: recent discoveries and novel treatment strategies
Suzanne A. Eccles et al.
LANCET (2007)
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis
K Shah et al.
MOLECULAR THERAPY (2005)
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
P Laakkonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
D Lawrence et al.
NATURE MEDICINE (2001)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
Share Paper
